Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI

Date:

Share post:

Cognizant has announced a new five-year, AI-enabled integrated IT operations agreement with Novartis, expanding a strategic relationship that spans more than two decades.

Under the multi-year deal, Cognizant will consolidate Novartis’ applications, infrastructure, cybersecurity, digital workplace, and platform services into a unified, end-to-end operating model. Powered by advanced AI, automation, and agentic capabilities, the transition aims to replace fragmented service delivery and optimize technology performance across Novartis’ global ecosystem.

Cognizant will utilize its engineering-led AI Builder approach and proprietary Cognizant Neuro® AI platform to enable predictive operations, autonomous self-service, full-stack observability, and AI-led software engineering. By streamlining IT complexity and improving user experience, the engagement creates a scalable, future-ready environment to support Novartis’ continued adoption of enterprise AI.

“We are proud to expand our long-standing partnership with Novartis and support its AI-driven transformation across the value chain,” said Manoj Mehta, President EMEA at Cognizant.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown

The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based...

From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story

Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a...

Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP

Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of...